UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Chevy Chase Trust Holdings LLC

Chevy Chase Trust Holdings LLC increased its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 697,335 shares of the healthcare conglomerate’s stock after acquiring an additional 28,940 shares during the period. UnitedHealth Group makes up about 1.1% of Chevy Chase Trust Holdings LLC’s investment portfolio, making the stock its 14th largest position. Chevy Chase Trust Holdings LLC’s holdings in UnitedHealth Group were worth $352,754,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. AlphaMark Advisors LLC purchased a new position in UnitedHealth Group in the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $37,000. Friedenthal Financial purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $51,000. DecisionPoint Financial LLC grew its stake in UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares in the last quarter. Finally, Highline Wealth Partners LLC purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $55,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on UNH shares. TD Cowen lifted their target price on UnitedHealth Group from $601.00 to $609.00 and gave the company a “buy” rating in a research note on Friday, October 18th. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. KeyCorp reiterated an “overweight” rating and set a $650.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Finally, Barclays reduced their price target on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating for the company in a report on Friday, January 17th. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company’s stock. Based on data from MarketBeat.com, UnitedHealth Group presently has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $531.31 on Friday. The company has a market cap of $488.96 billion, a P/E ratio of 34.28, a P/E/G ratio of 1.45 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The business’s 50 day moving average is $524.58 and its two-hundred day moving average is $563.71.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. UnitedHealth Group’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period in the previous year, the business posted $5.83 earnings per share. On average, equities analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.